Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

M.H.G. Rep, H.M. Schrijver, Th. van Lopik, R.Q. Hintzen, M.T.L. Roos, H.J. Ader, C.H. Polman, R.A.W. van Lier

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{83c00225b4574f1da12a89d80ef523a4,

title = "Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients",

author = "M.H.G. Rep and H.M. Schrijver and {van Lopik}, Th. and R.Q. Hintzen and M.T.L. Roos and H.J. Ader and C.H. Polman and {van Lier}, R.A.W.",

year = "1999",

doi = "10.1016/S0165-5728(98)00271-9",

language = "English",

volume = "96",

pages = "92--100",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

}

TY - JOUR

T1 - Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

AU - Rep, M.H.G.

AU - Schrijver, H.M.

AU - van Lopik, Th.

AU - Hintzen, R.Q.

AU - Roos, M.T.L.

AU - Ader, H.J.

AU - Polman, C.H.

AU - van Lier, R.A.W.

PY - 1999

Y1 - 1999

U2 - 10.1016/S0165-5728(98)00271-9

DO - 10.1016/S0165-5728(98)00271-9

M3 - Article

VL - 96

SP - 92

EP - 100

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -